Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time
Background: Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). Methods: We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK’s national COVID-19 Infection Survey, teste...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
eLife Sciences Publications Ltd
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb7c41c3ebf6484aa04bcf7f4a824a45 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fb7c41c3ebf6484aa04bcf7f4a824a45 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fb7c41c3ebf6484aa04bcf7f4a824a452021-11-15T14:41:28ZCt threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time10.7554/eLife.646832050-084Xe64683https://doaj.org/article/fb7c41c3ebf6484aa04bcf7f4a824a452021-07-01T00:00:00Zhttps://elifesciences.org/articles/64683https://doaj.org/toc/2050-084XBackground: Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). Methods: We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK’s national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Results: Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and 6550 (23%) for 3, 2, or 1 of the N, S, and ORF1ab genes, respectively, with median Ct = 29.2 (~215 copies/ml; IQR Ct = 21.9–32.8, 14–56,400 copies/ml). Independent predictors of lower Cts (i.e. higher viral load) included self-reported symptoms and more genes detected, with at most small effects of sex, ethnicity, and age. Single-gene positives almost invariably had Ct > 30, but Cts varied widely in triple-gene positives, including without symptoms. Population-level Cts changed over time, with declining Ct preceding increasing SARS-CoV-2 positivity. Of 6189 participants with IgG S-antibody tests post-first RT-PCR-positive, 4808 (78%) were ever antibody-positive; Cts were significantly higher in those remaining antibody negative. Conclusions: Marked variation in community SARS-CoV-2 Ct values suggests that they could be a useful epidemiological early-warning indicator. Funding: Department of Health and Social Care, National Institutes of Health Research, Huo Family Foundation, Medical Research Council UK; Wellcome Trust.A Sarah WalkerEmma PritchardThomas HouseJulie V RobothamPaul J BirrellIain BellJohn I BellJohn N NewtonJeremy FarrarIan DiamondRuth StudleyJodie HayKarina-Doris VihtaTimothy EA PetoNicole StoesserPhilippa C MatthewsDavid W EyreKoen B PouwelsCOVID-19 Infection Survey teameLife Sciences Publications LtdarticleSARS-CoV-2communityviral loadsymptomsMedicineRScienceQBiology (General)QH301-705.5ENeLife, Vol 10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
SARS-CoV-2 community viral load symptoms Medicine R Science Q Biology (General) QH301-705.5 |
spellingShingle |
SARS-CoV-2 community viral load symptoms Medicine R Science Q Biology (General) QH301-705.5 A Sarah Walker Emma Pritchard Thomas House Julie V Robotham Paul J Birrell Iain Bell John I Bell John N Newton Jeremy Farrar Ian Diamond Ruth Studley Jodie Hay Karina-Doris Vihta Timothy EA Peto Nicole Stoesser Philippa C Matthews David W Eyre Koen B Pouwels COVID-19 Infection Survey team Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time |
description |
Background: Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load).
Methods: We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK’s national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression.
Results: Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and 6550 (23%) for 3, 2, or 1 of the N, S, and ORF1ab genes, respectively, with median Ct = 29.2 (~215 copies/ml; IQR Ct = 21.9–32.8, 14–56,400 copies/ml). Independent predictors of lower Cts (i.e. higher viral load) included self-reported symptoms and more genes detected, with at most small effects of sex, ethnicity, and age. Single-gene positives almost invariably had Ct > 30, but Cts varied widely in triple-gene positives, including without symptoms. Population-level Cts changed over time, with declining Ct preceding increasing SARS-CoV-2 positivity. Of 6189 participants with IgG S-antibody tests post-first RT-PCR-positive, 4808 (78%) were ever antibody-positive; Cts were significantly higher in those remaining antibody negative.
Conclusions: Marked variation in community SARS-CoV-2 Ct values suggests that they could be a useful epidemiological early-warning indicator.
Funding: Department of Health and Social Care, National Institutes of Health Research, Huo Family Foundation, Medical Research Council UK; Wellcome Trust. |
format |
article |
author |
A Sarah Walker Emma Pritchard Thomas House Julie V Robotham Paul J Birrell Iain Bell John I Bell John N Newton Jeremy Farrar Ian Diamond Ruth Studley Jodie Hay Karina-Doris Vihta Timothy EA Peto Nicole Stoesser Philippa C Matthews David W Eyre Koen B Pouwels COVID-19 Infection Survey team |
author_facet |
A Sarah Walker Emma Pritchard Thomas House Julie V Robotham Paul J Birrell Iain Bell John I Bell John N Newton Jeremy Farrar Ian Diamond Ruth Studley Jodie Hay Karina-Doris Vihta Timothy EA Peto Nicole Stoesser Philippa C Matthews David W Eyre Koen B Pouwels COVID-19 Infection Survey team |
author_sort |
A Sarah Walker |
title |
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time |
title_short |
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time |
title_full |
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time |
title_fullStr |
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time |
title_full_unstemmed |
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time |
title_sort |
ct threshold values, a proxy for viral load in community sars-cov-2 cases, demonstrate wide variation across populations and over time |
publisher |
eLife Sciences Publications Ltd |
publishDate |
2021 |
url |
https://doaj.org/article/fb7c41c3ebf6484aa04bcf7f4a824a45 |
work_keys_str_mv |
AT asarahwalker ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT emmapritchard ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT thomashouse ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT julievrobotham ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT pauljbirrell ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT iainbell ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT johnibell ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT johnnnewton ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT jeremyfarrar ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT iandiamond ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT ruthstudley ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT jodiehay ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT karinadorisvihta ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT timothyeapeto ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT nicolestoesser ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT philippacmatthews ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT davidweyre ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT koenbpouwels ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime AT covid19infectionsurveyteam ctthresholdvaluesaproxyforviralloadincommunitysarscov2casesdemonstratewidevariationacrosspopulationsandovertime |
_version_ |
1718428352315916288 |